Meeting
2017 Gastrointestinal Cancers Symposium
Effect of adjuvant chemotherapy following pathologic complete response on long-term survival in rectal cancer: A propensity score matched analysis.
Authors
Ali Mokdad
University of Texas Southwestern, Dallas, TX
Ali Mokdad , Sergio Huerta , Rebecca M Minter , John C. Mansour , Michael A. Choti , Patricio Polanco
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 717)
DOI
10.1200/JCO.2017.35.4_suppl.717
Abstract #
717
Poster Bd #
K5
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Association of adjuvant chemotherapy with improved overall survival for patients with locally advanced rectal cancer (LARC) who achieve a pathologic complete response (pCR) to neoadjuvant chemoradiation (nCRT).
First Author: Danish Shahab
Poster
2021 ASCO Annual Meeting
Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).
First Author: Weiwei Xiao
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu
Poster
2017 ASCO Annual Meeting
Pathologic complete response rate after neoadjuvant chemoradiation in patients with locally advanced rectal cancer affects survival in patients with prolonged radiation-surgery interval.
First Author: Benjamin Mitchell Motz